Literature DB >> 33539918

KCC2 is required for the survival of mature neurons but not for their development.

Georgina Kontou1, Shu Fun Josephine Ng1, Ross A Cardarelli1, Jack H Howden2, Catherine Choi3, Qiu Ren3, Miguel A Rodriguez Santos3, Christopher E Bope3, Jake S Dengler3, Matt R Kelley3, Paul A Davies3, Josef T Kittler2, Nicholas J Brandon4, Stephen J Moss5, Joshua L Smalley3.   

Abstract

The K+/Cl- cotransporter KCC2 (SLC12A5) allows mature neurons in the CNS to maintain low intracellular Cl- levels that are critical in mediating fast hyperpolarizing synaptic inhibition via type A γ-aminobutyric acid receptors (GABAARs). In accordance with this, compromised KCC2 activity results in seizures, but whether such deficits directly contribute to the subsequent changes in neuronal structure and viability that lead to epileptogenesis remains to be assessed. Canonical hyperpolarizing GABAAR currents develop postnatally, which reflect a progressive increase in KCC2 expression levels and activity. To investigate the role that KCC2 plays in regulating neuronal viability and architecture, we have conditionally ablated KCC2 expression in developing and mature neurons. Decreasing KCC2 expression in mature neurons resulted in the rapid activation of the extrinsic apoptotic pathway. Intriguingly, direct pharmacological inhibition of KCC2 in mature neurons was sufficient to rapidly induce apoptosis, an effect that was not abrogated via blockade of neuronal depolarization using tetrodotoxin (TTX). In contrast, ablating KCC2 expression in immature neurons had no discernable effects on their subsequent development, arborization, or dendritic structure. However, removing KCC2 in immature neurons was sufficient to ablate the subsequent postnatal development of hyperpolarizing GABAAR currents. Collectively, our results demonstrate that KCC2 plays a critical role in neuronal survival by limiting apoptosis, and mature neurons are highly sensitive to the loss of KCC2 function. In contrast, KCC2 appears to play a minimal role in mediating neuronal development or architecture.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  KCC2; apoptosis; cell death; extrinsic pathway; seizures

Mesh:

Substances:

Year:  2021        PMID: 33539918      PMCID: PMC7949141          DOI: 10.1016/j.jbc.2021.100364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain.

Authors:  Martin Puskarjov; Faraz Ahmad; Kai Kaila; Peter Blaesse
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

2.  Impaired regulation of KCC2 phosphorylation leads to neuronal network dysfunction and neurodevelopmental pathology.

Authors:  Lucie I Pisella; Jean-Luc Gaiarsa; Diabé Diabira; Jinwei Zhang; Ilgam Khalilov; JingJing Duan; Kristopher T Kahle; Igor Medina
Journal:  Sci Signal       Date:  2019-10-15       Impact factor: 8.192

3.  Inability to suppress the stress-induced activation of the HPA axis during the peripartum period engenders deficits in postpartum behaviors in mice.

Authors:  Laverne Camille Melón; Andrew Hooper; Xuzhong Yang; Stephen J Moss; Jamie Maguire
Journal:  Psychoneuroendocrinology       Date:  2017-12-21       Impact factor: 4.905

4.  Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

Authors:  Jose A Pineda; Stephen B Lewis; Alex B Valadka; Linda Papa; H Julia Hannay; Shelley C Heaton; Jason A Demery; Ming Cheng Liu; Jada M Aikman; Veronica Akle; Gretchen M Brophy; Joseph J Tepas; Kevin K W Wang; Claudia S Robertson; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2007-02       Impact factor: 5.269

5.  Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.

Authors:  E A Slee; C Adrain; S J Martin
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

6.  A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures.

Authors:  T Saito; A Ishii; K Sugai; M Sasaki; S Hirose
Journal:  Clin Genet       Date:  2017-09-15       Impact factor: 4.438

7.  Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures.

Authors:  Yvonne E Moore; Tarek Z Deeb; Heramb Chadchankar; Nicholas J Brandon; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

8.  Apoptosis through Death Receptors in Temporal Lobe Epilepsy-Associated Hippocampal Sclerosis.

Authors:  Marcelo Ananias Teocchi; Lília D'Souza-Li
Journal:  Mediators Inflamm       Date:  2016-02-23       Impact factor: 4.711

9.  KCC2 Regulates Dendritic Spine Formation in a Brain-Region Specific and BDNF Dependent Manner.

Authors:  Patricia Nora Awad; Clara Akofa Amegandjin; Joanna Szczurkowska; Josianne Nuñes Carriço; Antônia Samia Fernandes do Nascimento; Elie Baho; Bidisha Chattopadhyaya; Laura Cancedda; Lionel Carmant; Graziella Di Cristo
Journal:  Cereb Cortex       Date:  2018-11-01       Impact factor: 5.357

10.  Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures.

Authors:  Tommy Stödberg; Amy McTague; Arnaud J Ruiz; Hiromi Hirata; Juan Zhen; Philip Long; Irene Farabella; Esther Meyer; Atsuo Kawahara; Grace Vassallo; Stavros M Stivaros; Magnus K Bjursell; Henrik Stranneheim; Stephanie Tigerschiöld; Bengt Persson; Iftikhar Bangash; Krishna Das; Deborah Hughes; Nicole Lesko; Joakim Lundeberg; Rod C Scott; Annapurna Poduri; Ingrid E Scheffer; Holly Smith; Paul Gissen; Stephanie Schorge; Maarten E A Reith; Maya Topf; Dimitri M Kullmann; Robert J Harvey; Anna Wedell; Manju A Kurian
Journal:  Nat Commun       Date:  2015-09-03       Impact factor: 14.919

View more
  6 in total

Review 1.  Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken.

Authors:  Wolfgang Liedtke
Journal:  Front Mol Neurosci       Date:  2022-05-13       Impact factor: 6.261

2.  Delineation of the functional properties exhibited by the Zinc-Activated Channel (ZAC) and its high-frequency Thr128Ala variant (rs2257020) in Xenopus oocytes.

Authors:  Nawid Madjroh; Paul A Davies; Joshua L Smalley; Uffe Kristiansen; Pella C Söderhielm; Anders A Jensen
Journal:  Pharmacol Res       Date:  2021-05-04       Impact factor: 7.658

3.  Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission.

Authors:  Michele Yeo; Yong Chen; Changyu Jiang; Gang Chen; Kaiyuan Wang; Sharat Chandra; Andrey Bortsov; Maria Lioudyno; Qian Zeng; Peng Wang; Zilong Wang; Jorge Busciglio; Ru-Rong Ji; Wolfgang Liedtke
Journal:  Nat Commun       Date:  2021-10-27       Impact factor: 14.919

4.  Loss of KCC2 in GABAergic Neurons Causes Seizures and an Imbalance of Cortical Interneurons.

Authors:  Kirill Zavalin; Anjana Hassan; Cary Fu; Eric Delpire; Andre H Lagrange
Journal:  Front Mol Neurosci       Date:  2022-03-16       Impact factor: 5.639

5.  Role of GABAA receptor depolarization-mediated VGCC activation in sevoflurane-induced cognitive impairment in neonatal mice.

Authors:  Shuang Zeng; Ruilou Zhu; Yangyang Wang; Yitian Yang; Ningning Li; Ningning Fu; Mingyang Sun; Jiaqiang Zhang
Journal:  Front Cell Neurosci       Date:  2022-09-13       Impact factor: 6.147

6.  Analyzing the mechanisms that facilitate the subtype-specific assembly of γ-aminobutyric acid type A receptors.

Authors:  Catherine Choi; Joshua L Smalley; Abigail H S Lemons; Qiu Ren; Christopher E Bope; Jake S Dengler; Paul A Davies; Stephen J Moss
Journal:  Front Mol Neurosci       Date:  2022-10-03       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.